Catalan biomedical companies attracted €102 million in investment in 2017, with €3.4 million per operation, on average. This will allow them to push forward in the development of drugs and innovat...
Read moreAño tras año crece el número de empresas que apuestan por el uso eficiente de los recursos naturales, por ello y ante la necesidad de crear un espacio de colaboración interdisciplinar para impulsa...
Read moreOne more year, the Barcelona Science Park (PCB) participates in BIO International Convention, the largest global event for the biotech and pharmaceutical sector hosted annually by the Biotechnology In...
Read moreThe Scientific and Technological Centers of the University of Barcelona (CCiTUB) reached their first thirty years of activity over which they have become widely known in both the national and internat...
Read moreEl Parc Científic de Barcelona (PCB), la Fundación Bosch i Gimpera (FBG) y el Barcelona Instituto de Emprendimiento (BIE) han dado el pistoletazo de salida al programa de acceleración MedTeX, una i...
Read moreEl pasado, 10 de mayo, tuvo lugar en el Parc Científic de Barcelona (PCB) la celebración del 10º aniversario de la Fundación DTI (Donation & Transplantation Institute), que nació en 2008 para dar...
Read moreThe Chan Zuckerberg Initiative (CZI) an advised fund of Silicon Valley Community Foundation, today announced new funding for 85 projects to support the Human Cell Atlas (HCA), a global effort to map e...
Read moreLa compañía gallega GalChimia, especializada en productos y servicios de química orgánica para el sector farmacéutico, ha inaugurado hoy un centro de I+D+i en el Parc Científic de Barcelona (PCB...
Read moreThe Live Research Fair, which opens its doors today at CosmoCaixa Barcelona until Saturday 14 April, aims to raise public awareness of research by opening up dialogue between the community and researc...
Read moreReig Jofre and LeanBio, based at the Barcelona Science Park (PCB), have created the joint venture Syna Therapeutics qfor the development of biopharmaceutical products in the field of biosimilar produc...
Read moreSubject to the successful completion of defined development activities by Stat-Dx, Qiagen has agreed to acquire all shares of Stat-Dx for approximately $147 million in cash and additional payments of ...
Read moreEn el marco del nuevo programa Wild Card, el consorcio EIT Health, el mayor organismo europeo para la innovación en vida saludable y envejecimiento activo, ha anunciado una financiación de 4 M€ pa...
Read more